Merck & Co. Inc.
- Price
- 131.07 USD
- Fair value
- 56.17 USD
- Discount to fair value
- −133%
- Mkt cap
- 323.72B
- P/E
- 17.7×
- P/B
- 6.15×
- EV
- 358.49B
- Div yield
- 2.53%
- ROE
- 34.7%
- Net margin
- 28.1%
Current price131.07USD
Fair value (est., median)56.17USD
UndervaluedFair valueOvervalued
+133.3% above fair valueWould need to fall ~57.1% to reach fair value.
Median ofDCF 65.47DDM 42.16Graham 56.17Residual Income 66.06Earnings Power 54.87
Health Check
51.4
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Rewards
- Strong return on equity (34.7%).
- Attractive, covered dividend (2.53%).
Risks
- Trades 133.3% above estimated fair value.
- Expensive on book (P/B 6.2×).
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for details
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
Covers 19 years · FY2007–FY2025
| Metric | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Revenue | 48.70B | 59.28B | 60.12B | 64.17B | 65.01B |
| Net Income | 13.05B | 14.52B | 365.00M | 17.12B | 18.25B |
| Net Margin | 26.8% | 24.5% | 0.6% | 26.7% | 28.1% |
| Operating Cash Flow | 13.12B | 19.09B | 13.01B | 21.47B | 16.47B |
| OCF Margin | 26.9% | 32.2% | 21.6% | 33.5% | 25.3% |
| Capital Expenditure | 4.45B | 4.39B | 3.86B | 3.37B | 4.11B |
| Free Cash Flow | 8.67B | 14.71B | 9.14B | 18.10B | 12.36B |
| FCF Margin | 17.8% | 24.8% | 15.2% | 28.2% | 19.0% |
| FCF Conversion | 66.5% | 101.3% | 2,504.9% | 105.7% | 67.7% |
| EPS (Diluted) | 5.28/sh | 5.88/sh | 0.15/sh | 6.93/sh | 7.39/sh |
| Dividend / Share | 2.68/sh | 2.84/sh | 3.01/sh | 3.17/sh | 3.31/sh |
Dividend return (if you buy today)if you buy today
Dividend yield2.53%
Dividend / share3.31 USD
If you invest
USD
Shares (≈)76
Est. annual income251.59 USD
At this rate, dividends alone return your capital in ~39.6 years.
Dividend history
Dividend / share & historical yield (USD).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · USD
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | 0.85 | 0.85 | — | — | 1.70 | 1.4% |
| 2025 | — | — | — | — | 3.31 | 3.7% |
| 2024 | — | — | — | — | 3.17 | 2.7% |
| 2023 | — | — | — | — | 3.01 | 2.8% |
| 2022 | — | — | — | — | 2.84 | 3.1% |
Corporate actions
DCash Dividend
0.85 USD /sh2026-06-15
DCash Dividend
0.85 USD /sh2026-03-16
SStock Split
1.048×2021-06-03
DCash Dividend
0.36 USD /sh2004-09-01
DCash Dividend
0.35 USD /sh2004-06-02
DCash Dividend
0.35 USD /sh2004-03-03
DCash Dividend
0.35 USD /sh2003-12-03
DCash Dividend
0.35 USD /sh2003-09-03
DCash Dividend
2.74 USD /sh2003-08-20
DCash Dividend
0.34 USD /sh2003-06-04
Valuation breakdown
Fair value = median of the applicable methods (DCF، DDM، Graham، Residual Income، Earnings Power).
Each method below is a different lens on the same company — no single method dominates the result.
Discounted Cash Flow
Values the company from the future cash it's expected to generate. · Tap to adjust assumptions
65.47 USD
Dividend Discount Model
Values the share from the dividends it's expected to keep paying. · Tap to adjust assumptions
42.16 USD
Graham Number
A conservative benchmark built from earnings and book value. · Tap to adjust assumptions
56.17 USD
Residual Income (justified P/B)
Values the profit the company earns above the cost of its equity. · Tap to adjust assumptions
66.06 USD
Earnings Power Value
Values today's earning power as-is, assuming no growth. · Tap to adjust assumptions
54.87 USD
DCF only is anchored on FY2025 — the latest year with positive cash flow that supports a value. The other methods (DDM, Graham, RIM, EPV) use current / normalized figures.
Fair Value (median)56.17 USD
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 11.09%
- CAPM cost of equity
- 12.00%
- Risk-free rate
- 4.50%
- Equity risk premium
- 7.50%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 10
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in Merck & Co. Inc. regularly?
Starting year
- Invested
- 1K/yr · 42K total(1985 → today · 42 yrs)
- your value today is
- 270.3K USD
- Total return
- +543.6%(+47.4% Dividends · +496.2% Capital gain)
- Annualised (IRR)
- +8.8%
Invested42KUSD
Dividends19.9KUSD
Capital gain208.4KUSD
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.